The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 325.00
Ask: 326.00
Change: 3.50 (1.08%)
Spread: 1.00 (0.308%)
Open: 328.50
High: 329.50
Low: 322.50
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

6 Dec 2022 07:00

RNS Number : 6717I
Morgan Advanced Materials PLC
06 December 2022
 

Press Release

Morgan Advanced Materials plc

6 December 2022

 

Capital Markets Event

"Delivering resilient, scalable growth"

Morgan Advanced Materials plc will hold a Capital Markets Event this afternoon at the Science Museum in London.

The event will include a series of presentations by our senior leadership team, which will focus on our opportunities for profitable growth as a global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications. These include specific initiatives to drive sustainable growth through the industrial cycle.

We also set out the following through the cycle financial objectives:

- Accelerating Organic Revenue Growth. Extending our position in faster growing markets, supporting 3-6% p.a.

- Attractive Margins. 12.5% - 15% adjusted operating profit margin

- Delivering EPS Growth.  Achieving enhanced growth in adjusted Earnings per Share, ahead of organic revenue growth, driven by a combination of organic growth, inorganic activity and shareholder returns

- Leverage Range. 1.0x to 2.0x adjusted EBITDA

- Sustaining ROIC. 17 - 20% ROIC

In addition, we set out the following capital allocation policies:

- Focussing Organic Investment.  Investment to enhance growth and returns, including an additional £60m of capital in our Semiconductor manufacturing capacity over the next few years

- Enhancing Regular Returns via a Progressive Dividend Policy. Grow the regular dividend through the cycle with an adjusted earnings cover of c.2.5x

- Inorganic Activity. Complementary, disciplined M&A focused on accelerating revenue growth opportunities in faster growing markets

- Additional Returns. Additional returns of surplus capital to shareholders as appropriate.

The presentation for the event will be made available at www.morganadvancedmaterials.com at 14:00 UK time today. A recording of the presentation will be made available following the event.

Accelerated Pension Contribution

We have agreed with the Trustees of our UK Defined Benefit Pension Schemes a contribution of £67m that will create further balance sheet flexibility whilst substantially reducing future cash contributions. Further detail is provided in a separate RNS released today.

RCF Renewal

We have secured a new five-year Revolving Credit Facility of £230m that replaces our existing RCF that was due to mature in 2023.

FY22 Guidance

Our outlook and guidance for full year 2022 provided in our Trading Update of 4 November 2022 remain unchanged.

 

For further enquiries:

Pete Raby, CEO

Morgan Advanced Materials plc

01753 837000

Richard Armitage, CFO

Nina Coad

Brunswick

0207 404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSWRUBUURAA
Date   Source Headline
14th Oct 20149:29 amRNSHolding(s) in Company
2nd Oct 201411:25 amRNSDirector/PDMR Shareholding
29th Sep 20147:00 amRNSBoard Change
23rd Sep 20149:42 amRNSHolding(s) in Company
22nd Aug 201410:59 amRNSHolding(s) in Company
18th Aug 201410:16 amRNSHalf Yearly Report
5th Aug 20149:53 amRNSUNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN
1st Aug 20149:18 amRNS£15m Composites & Defence Systems Contract Award
31st Jul 20142:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSHalf Year Results
18th Jul 20149:25 amRNSDirector Declaration
15th Jul 20147:00 amRNSAcquisition of Porextherm Dämmstoffe GmbH
14th Jul 20149:15 amRNSDirector Declaration
18th Jun 20148:16 amRNSChange of Directors' responsibilities
16th Jun 201412:01 pmRNSBlocklisting Interim Review
9th Jun 20143:10 pmRNSHolding(s) in Company
9th Jun 201412:28 pmRNSAcquisition of Porextherm Dämmstoffe GmbH
9th Jun 201410:39 amRNSDirector/PDMR Shareholding
9th May 20143:39 pmRNSResult of AGM
9th May 20147:00 amRNSInterim Management Statement
9th Apr 201410:42 amRNSDirector/PDMR Shareholding
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.